OLIG2

oligodendrocyte transcription factor 2, the group of Basic helix-loop-helix proteins

Basic information

Region (hg38): 21:33025935-33029196

Previous symbols: [ "PRKCBP2", "BHLHB1" ]

Links

ENSG00000205927NCBI:10215OMIM:606386HGNC:9398Uniprot:Q13516AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OLIG2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OLIG2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
11
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 11 0 0

Variants in OLIG2

This is a list of pathogenic ClinVar variants found in the OLIG2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
21-33026915-A-C not specified Uncertain significance (Aug 12, 2022)2306750
21-33027001-T-C not specified Uncertain significance (Nov 14, 2023)3204281
21-33027194-T-G not specified Uncertain significance (Oct 30, 2023)3204282
21-33027211-G-A Inborn genetic diseases Uncertain significance (Nov 03, 2017)522166
21-33027261-G-T not specified Uncertain significance (Jan 03, 2024)3204283
21-33027461-C-G not specified Uncertain significance (Dec 01, 2022)2330738
21-33027532-C-T not specified Uncertain significance (Jul 30, 2023)2599547
21-33027543-A-G EBV-positive nodal T- and NK-cell lymphoma Likely benign (-)2681451
21-33027634-C-T not specified Uncertain significance (Aug 16, 2021)2245406
21-33027694-G-A not specified Uncertain significance (May 25, 2022)2290832
21-33027730-G-T not specified Uncertain significance (Nov 18, 2022)2394405
21-33027788-C-G not specified Uncertain significance (Jun 03, 2024)3302298
21-33027803-G-C not specified Uncertain significance (May 23, 2023)2549946

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OLIG2protein_codingprotein_codingENST00000333337 13352
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.09460.78000000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.66871430.6090.000006572032
Missense in Polyphen1350.5640.2571537
Synonymous-1.107765.71.170.00000327718
Loss of Function1.1624.730.4232.02e-758

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Functions together with ZNF488 to promote oligodendrocyte differentiation. Cooperates with OLIG1 to establish the pMN domain of the embryonic neural tube. Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development. {ECO:0000250|UniProtKB:Q9EQW6}.;
Disease
DISEASE: Note=A chromosomal aberration involving OLIG2 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(14;21)(q11.2;q22) with TCRA. {ECO:0000269|PubMed:10737801}.;
Pathway
Neural Crest Differentiation (Consensus)

Recessive Scores

pRec
0.360

Haploinsufficiency Scores

pHI
0.576
hipred
Y
hipred_score
0.577
ghis
0.619

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.854

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Olig2
Phenotype
cellular phenotype; muscle phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm;

Zebrafish Information Network

Gene name
olig2
Affected structure
dopaminergic neuron
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;spinal cord motor neuron differentiation;spinal cord oligodendrocyte cell fate specification;thalamus development;myelination;negative regulation of neuron differentiation;neuron fate commitment;positive regulation of oligodendrocyte differentiation
Cellular component
nucleus;cytoplasm
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein homodimerization activity;HMG box domain binding